Flexion Therapeutics Inc (FLXN) [Rocket]

Overview

Flexion Therapeutics Inc (FLXN)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
11/29/2021	15-12B	Form 15-12B - Securities registration termination [Section 12(b)]:
11/26/2021	EFFECT	Form EFFECT - Notice of Effectiveness:
11/23/2021	4	Newtyn Management, LLC (10% Owner) has filed a Form 4 on Flexion Therapeutics Inc
11/23/2021	3	Newtyn Management, LLC (10% Owner) has filed a Form 3 on Flexion Therapeutics Inc
11/19/2021	4	Stejbach Mark (Director) has filed a Form 4 on Flexion Therapeutics Inc
11/19/2021	4	MILINAZZO ALAN (Director) has filed a Form 4 on Flexion Therapeutics Inc
11/19/2021	4	MERRIFIELD C ANN (Director) has filed a Form 4 on Flexion Therapeutics Inc

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14	Dec-31-13
Revenues	85.6	73.0	22.5	0.4	0.0	0.0	0.0	0.0
Revenue growth	17.3%	223.9%	6244.8%
Cost of goods sold	19.2	10.0	7.3	0.0	0.0	0.0	0.0	0.0
Gross profit	66.3	63.0	15.2	0.4	0.0	0.0	0.0	0.0
Gross margin	77.5%	86.3%	67.4%	98.9%
Selling, general and administrative	105.0	129.7	121.3	78.8	28.5	13.4
Research and development	54.3	69.6	53.1	51.2	41.3	32.7	17.9	11.1
General and administrative							9.1	6.7
EBIT	-93.0	-136.3	-159.2	-129.7	-69.8	-46.1	-27.0	-17.8
EBIT margin	-108.7%	-186.8%	-706.8%	-36529.9%
Pre-tax income	-113.2	-149.8	-169.7	-137.5	-71.9	-46.3	-27.3	-18.2
Income taxes	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate		0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-113.7	-149.8	-169.7	-137.5	-71.9	-46.3	-27.3	-18.2
Net margin	-132.9%	-205.3%	-753.2%	-38727.0%

Diluted EPS	($2.53)	($3.93)	($4.49)	($4.16)	($2.84)	($2.15)	($1.97)	($23.02)
Shares outstanding (diluted)	45.0	38.1	37.8	33.0	25.3	21.5	13.9	0.8

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.